Skip to main content
. 2026 Feb 24;18(5):728. doi: 10.3390/cancers18050728
DOAC Direct Oral Anticoagulant
ET Essential Thrombocythemia
GU Genito-Urinary
HRT Hormone replacement therapy
IFN Interferon
MPN Myeloproliferative Neoplasm
MF Myelofibrosis
Peg Pegylated
PV Polycythemia vera
SNRI Selective norepinephrine reuptake inhibitor
SSRI Selective serotonin reuptake inhibitor
VTE Venous Thromboembolism
WHI Women’s Health Initiative